Most Sofia bourse indices fall, Fibank paces blue-chip losers
UPDATE 1 - Bulgarian regulator okays 6.5% hike in Dec natgas price
Zarneni Hrani Bulgaria boosts 9-mo cons net profit, revenue falls
Fitch reaffirms Euroins Insurance Group at B+, outlook stable
Croatia's competition watchdog opens probe into Cakovecki Mlinovi, Tvornica Stocne Hrane
Dec 15, 2017 14:38 EEST
SOFIA (Bulgaria), December 15 (SeeNews) – Bulgarian drug maker Sopharma [BUL:3JR] said on Friday it acquired 3,000 of its own shares at an average weighted price of 4.285 levs ($2.6/2.2 euro) apiece on December 14.
The shares, acquired as part of the company's share repurchase programme, represent a 0.0022% stake in Sopharma, the drug maker said in a statement.
On Thursday, Sopharma said it has acquired 6,251 of its own shares on December 13.
Currently, Sopharma holds 8.89 million of its own shares, equal to a 6.60% stake in the company.
Sopharma plans to repurchase 10% of its own shares under a buyback programme approved in June 2010.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options